COVID-19 and diabetes mellitus: from pathophysiology to clinical management

S Lim, JH Bae, HS Kwon, MA Nauck - Nature Reviews Endocrinology, 2021 - nature.com
Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …

COVID-19 in people with diabetes: understanding the reasons for worse outcomes

M Apicella, MC Campopiano, M Mantuano… - The lancet Diabetes & …, 2020 - thelancet.com
Since the initial COVID-19 outbreak in China, much attention has focused on people with
diabetes because of poor prognosis in those with the infection. Initial reports were mainly on …

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

AK Singh, R Gupta, A Ghosh, A Misra - Diabetes & Metabolic Syndrome …, 2020 - Elsevier
Background and aims High prevalence of diabetes makes it an important comorbidity in
patients with COVID-19. We sought to review and analyze the data regarding the …

Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis

A Kumar, A Arora, P Sharma, SA Anikhindi… - Diabetes & Metabolic …, 2020 - Elsevier
Background Many studies on COVID-19 have reported diabetes to be associated with
severe disease and mortality, however, the data is conflicting. The objectives of this meta …

COVID-19 and diabetes: understanding the interrelationship and risks for a severe course

CP Landstra, EJP de Koning - Frontiers in endocrinology, 2021 - frontiersin.org
The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional.
On the one hand, diabetes mellitus is considered one of the most important risk factors for a …

Diabetes and COVID-19: A systematic review on the current evidences

A Abdi, M Jalilian, PA Sarbarzeh… - Diabetes research and …, 2020 - Elsevier
Background COVID-19 pneumonia is a newly recognized illness that is spreading rapidly
around the world and causes many disability and deaths. Some diseases, for instance …

Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control …

SB Solerte, F D'Addio, R Trevisan, E Lovati… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE Poor outcomes have been reported in patients with type 2 diabetes and
coronavirus disease 2019 (COVID-19); thus, it is mandatory to explore novel therapeutic …

Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis

SMM Aghili, M Ebrahimpur, B Arjmand… - International journal of …, 2021 - nature.com
Background Recent studies have shown that obesity is associated with the severity of
coronavirus disease (COVID-19). We reviewed clinical studies to clarify the obesity …

COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

S Colafrancesco, C Alessandri, F Conti, R Priori - Autoimmunity reviews, 2020 - Elsevier
The severe form of COVID-19 share several clinical and laboratory features with four entities
gathered under the term “hyperferritinemic syndromes” and including macrophage activation …

COVID-19 and diabetes: A bidirectional relationship

MM Lima-Martínez, CC Boada… - Clínica e Investigación …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of
coronavirus disease 2019 (COVID-19). Diabetes is one of the most frequent comorbidities in …